Integra LifeSciences (IART) Competitors $14.83 -0.24 (-1.59%) Closing price 04:00 PM EasternExtended Trading$14.76 -0.06 (-0.44%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IART vs. ITGR, ATEC, ATRC, OFIX, SRDX, ANGO, ARAY, RMTI, RSLS, and ABTShould you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), and Abbott Laboratories (ABT). These companies are all part of the "health care equipment" industry. Integra LifeSciences vs. Its Competitors Integer Alphatec AtriCure Orthofix Medical Surmodics AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Integra LifeSciences (NASDAQ:IART) and Integer (NYSE:ITGR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment. Which has more volatility & risk, IART or ITGR? Integra LifeSciences has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Integer has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Does the media favor IART or ITGR? In the previous week, Integer had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 8 mentions for Integer and 4 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.41 beat Integer's score of 0.93 indicating that Integra LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in IART or ITGR? 84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 3.5% of Integra LifeSciences shares are held by insiders. Comparatively, 2.2% of Integer shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is IART or ITGR more profitable? Integer has a net margin of 4.61% compared to Integra LifeSciences' net margin of -30.87%. Integer's return on equity of 12.27% beat Integra LifeSciences' return on equity.Company Net Margins Return on Equity Return on Assets Integra LifeSciences-30.87% 12.15% 4.32% Integer 4.61%12.27%6.23% Do analysts prefer IART or ITGR? Integra LifeSciences currently has a consensus price target of $18.43, suggesting a potential upside of 24.09%. Integer has a consensus price target of $140.25, suggesting a potential upside of 36.29%. Given Integer's stronger consensus rating and higher possible upside, analysts clearly believe Integer is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Integra LifeSciences 4 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.78Integer 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, IART or ITGR? Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntegra LifeSciences$1.62B0.71-$6.94M-$6.53-2.27Integer$1.72B2.10$119.90M$2.2745.33 SummaryInteger beats Integra LifeSciences on 14 of the 17 factors compared between the two stocks. Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IART vs. The Competition Export to ExcelMetricIntegra LifeSciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.16B$6.67B$5.70B$10.27BDividend YieldN/A1.21%5.72%4.60%P/E Ratio-2.2826.6175.8126.51Price / Sales0.71195.81492.95166.26Price / Cash3.3822.1825.8129.90Price / Book0.744.9612.836.31Net Income-$6.94M$176.38M$3.28B$270.12M7 Day Performance-3.75%4.98%0.24%2.04%1 Month Performance4.66%7.29%4.59%6.25%1 Year Performance-14.26%10.62%68.69%25.50% Integra LifeSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IARTIntegra LifeSciences3.7747 of 5 stars$14.83-1.6%$18.43+24.3%-13.7%$1.16B$1.62B-2.274,396Positive NewsITGRInteger3.9526 of 5 stars$106.01-0.9%$140.25+32.3%-21.0%$3.75B$1.72B46.7011,000ATECAlphatec4.1727 of 5 stars$16.34-0.4%$18.50+13.2%+169.2%$2.43B$611.56M-14.46700Positive NewsATRCAtriCure2.5123 of 5 stars$36.00+1.8%$50.89+41.4%+22.8%$1.76B$465.31M-46.751,300News CoverageInsider TradeOFIXOrthofix Medical3.4897 of 5 stars$14.70+1.0%$21.50+46.3%-12.0%$574.64M$799.49M-4.641,616Positive NewsSRDXSurmodics4.5532 of 5 stars$32.93+1.7%$43.00+30.6%-17.8%$462.96M$126.08M-26.77450Positive NewsANGOAngioDynamics4.1642 of 5 stars$10.90+1.6%$19.00+74.3%+37.4%$436M$292.50M-13.13760Positive NewsARAYAccuray4.7559 of 5 stars$1.55+2.6%$5.00+222.6%-26.5%$170.14M$458.51M-77.501,040Positive NewsAnalyst UpgradeRMTIRockwell Medical3.798 of 5 stars$1.59-1.9%$4.00+151.6%-57.2%$55.78M$101.49M-26.50300Gap UpRSLSReShape LifesciencesN/A$3.16-1.4%N/A-99.7%$8.49M$8.01M-0.0350Gap DownHigh Trading VolumeABTAbbott Laboratories4.913 of 5 stars$132.27-0.5%$144.47+9.2%+12.9%$231.38B$41.95B16.58114,000Positive News Related Companies and Tools Related Companies ITGR Alternatives ATEC Alternatives ATRC Alternatives OFIX Alternatives SRDX Alternatives ANGO Alternatives ARAY Alternatives RMTI Alternatives RSLS Alternatives ABT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IART) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IART Stock Alerts